Dr. Phillip Pierorazio, originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City. Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. After completing residency and advanced training at the Johns Hopkins Hospital, he joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology.
Dr. Pierorazio has expertise in all malignancies of the urinary tract, including kidney, bladder, prostate, testis, adrenal, penile and urethral cancer. He performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder and prostate. He has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers.
Paralleling his clinical interests, his research interests and publications include high-risk urologic malignancies including prostate and bladder cancer. He has a special interest in kidney cancer (renal cell carcinoma), studying both advanced and early-stage disease. He runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry – one of the largest studies of its kind – following patients with small, localized kidney tumors (cT1a, ≤4cm) who choose active surveillance or immediate surgery. The National Comprehensive Cancer Network (NCCN) recently awarded Dr. Pierorazio a Young Investigator’s Award for his work with the DISSRM Registry.
Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.